Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 625-636 of 1,136
Drug study icon
CompletedNCT02579642

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In Canada
DepressionDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Depression
Behavioral study icon
CompletedNCT03189810

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Canada
Schizophrenia, AddictionBehavioralFrom 18 Years to 55 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia, Addiction
Device study icon
CompletedNCT01523730

Effects of rTMS on Cigarette Smoking and Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
Schizophrenia, AddictionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia, Addiction
Drug study icon
CompletedNCT01934023

Effects of Varenicline on Plasticity in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05315609

Effects of Virtual Reality Meditation in Older Adults

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
Mental healthBehavioralOver 60 Years
Countries
Canada
Sponsor
Lady Davis Institute
Condition
Mental health
Drug study icon
CompletedNCT02970292

Pimavanserin for schizophrenia

This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00439634

AVE1625 for schizophrenia

This study was terminated in the United States and in Canada. It is testing AVE1625 for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
Sanofi
Condition
Schizophrenia
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

In Canada
ADHDDrugFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In Canada
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01267188

NBI-98854 for adults with tardive dyskinesia

This study is completed in Canada. It focuses on adults with tardive dyskinesia.

In Canada
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.